Effect of vaccination on protection against RHDV-2 and viral load
Publications
Rabbits
Appeared in
SVEPM Conference, 2018
The aim of this study was to assess the clinical course, viral load, survival rate and humoral immune response of animals vaccinated with ERAVAC® after experimental RHDV2 infection at 6 months post-vaccination.
Download this article
Related products
Recombinant vaccine against rabbit haemorrhagic disease (RHD) caused by the classical (RHDV) and variant (RHDV2) strains, including highly virulent strains, in an emulsion for injection.
Inactivated vaccine against the variant strain of rabbit haemorrhagic disease (RHDV-2), in injectable emulsion.
Inactivated vaccine against the variant strain of rabbit haemorrhagic disease (RHDV-2), in injectable emulsion.
Live heterologous vaccine against myxomatosis, in injectable freeze-dried tablet.
Live homologous vaccine against myxomatosis, in injectable freeze-dried tablet
Inactivated vaccine against the classic strain of rabbit haemorrhagic disease (RHDV1), in injectable emulsion
Enrofloxacin, in oral solution, animal medicine, animal medicines, medicine for rabbits, rabbit medicine, medicine for poultry
Related services
HIPRA University offers high quality training programmes in strategic areas of interest for professionals
Access an advanced diagnostic service with maximum comfort and reliability
